Factors Influencing the Efficacy of Low-Dose Spironolactone in Adults with Chronic Kidney Disease and Type 2 Diabetes: A post hoc Analysis
It may not be too late to start treatment with low-dose spironolactone, even in patients with relatively advanced CKD with diabetes.
Authors
- Mitsuhisa Komatsu (ORCID: https://orcid.org/0000-0002-1359-9732)
- Takahide Miyamoto
- Ako Oiwa (ORCID: https://orcid.org/0000-0002-7765-9466)
- Shohei Takayama
- Masayoshi Koinuma (ORCID: https://orcid.org/0009-0005-2959-4265)
- Dai Hiwatashi
- Teiji Takeda
Institutions
- Teikyo Heisei University (JP)
- Shinshu University (JP)
- Takeda (Japan) (JP)
- Matsumoto University (JP)
Publication Details
- Journal
- Kidney & Blood Pressure Research
- Published
- 2025-12-14
- DOI
- https://doi.org/10.1159/000549942
- Primary Topic
- Dialysis and Renal Disease Management
- Type
- article
- Field-Weighted Citation Impact
- 0.00